Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapy.
Brendel C, Hänseler W, Wohlgensinger V, Bianchi M, Tokmak S, Chen-Wichmann L, Kuzmenko E, Cesarovic N, Nicholls F, Reichenbach J, Seger R, Grez M, Siler U.
Brendel C, et al. Among authors: reichenbach j.
Hum Gene Ther Methods. 2013 Jun;24(3):151-9. doi: 10.1089/hgtb.2012.157. Epub 2013 May 2.
Hum Gene Ther Methods. 2013.
PMID: 23489116
Free PMC article.